CANCER IMMUNOTHERAPY – AN EMERGING FIELD
Ananya De*
College of Pharmacy, University of Minnesota, Twin City Campus, Minneapolis, MN 55455-0213, U.S.A.
*Corresponding Author:
E-mail: de.ananya@gmail.com Tel.: +1 631 265 2860
ABSTRACT
Immunotherapy directed at activating the body’s immune system against cancer cells is an exciting field in
oncology. In order to circumvent many pitfalls in the area, ongoing research has used monoclonal antibodies,
cytokines and cancer vaccines to specifically target and destroy tumor cells. Clinical trials have been conducted
with success that use immunotherapies alone or with conventional chemotherapies to address various types of
cancers. This short review mentions the significant improvements in the area, as well as remaining challenges
to be addressed. Cancer immunotherapy is a developing area that holds many promises. Future years will show
if efficient and durable anti-tumor action is provided through these novel approaches.
Keywords: cancer, immunotherapy, monoclonal antibodies, cytokines, vaccines.
Keywords:
cancer, immunotherapy, monoclonal antibodies, cytokines, vaccines